| $385M | ||
| $337M | ||
| $100M | ||
| $87M | ||
| $82M | ||
| $62M |
Buys | $44,275,008 | 3 | 38 |
Sells | $246,038 | 5 | 62 |
| Apeiron Investment Group Ltd. | 10 percent owner | 3 | $44.28M | 0 | $0 | $44.28M |
| Craig Kevin James | Chief Medical Officer | 0 | $0 | 1 | $15,610 | $-15,610 |
| Short Glenn Frank | Chief Scientific Officer | 0 | $0 | 1 | $17,767 | $-17,767 |
| Johnson Anne Nagengast | Chief Financial Officer | 0 | $0 | 1 | $45,286 | $-45,286 |
| Kirpekar Sahil | Chief Business Officer | 0 | $0 | 1 | $65,560 | $-65,560 |
| Rao Srinivas | See Remarks | 0 | $0 | 1 | $101,814 | $-101,814 |
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
Over the last 12 months, insiders at Atai Beckley N.V have bought $44.28M and sold $246,038 worth of Atai Beckley N.V stock.
On average, over the past 5 years, insiders at Atai Beckley N.V have bought $17.28M and sold $383,757 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Apeiron Investment Group Ltd. (10 percent owner) — $44.28M.
The last purchase of 8,675,799 shares for transaction amount of $19M was made by Apeiron Investment Group Ltd. (10 percent owner) on 2025‑08‑14.
| 2025-08-14 | Apeiron Investment Group Ltd. | 10 percent owner | 8.68M 2.3602% | $2.19 | $19M | +15.96% | ||
| 2025-03-24 | Apeiron Investment Group Ltd. | 10 percent owner | 1.8M 0.8274% | $1.40 | $2.52M | +138.85% | ||
| 2025-03-21 | Sale | Rao Srinivas | See Remarks | 75,418 0.0362% | $1.35 | $101,814 | +157.93% | |
| 2025-03-21 | Sale | Johnson Anne Nagengast | Chief Financial Officer | 33,545 0.0161% | $1.35 | $45,286 | +157.93% | |
| 2025-03-21 | Sale | Kirpekar Sahil | Chief Business Officer | 48,563 0.0233% | $1.35 | $65,560 | +157.93% | |
| 2025-03-21 | Sale | Short Glenn Frank | Chief Scientific Officer | 13,161 0.0063% | $1.35 | $17,767 | +157.93% | |
| 2025-03-21 | Sale | Craig Kevin James | Chief Medical Officer | 11,563 0.0055% | $1.35 | $15,610 | +157.93% | |
| 2025-02-14 | Apeiron Investment Group Ltd. | 10 percent owner | 10.84M 5.9738% | $2.10 | $22.76M | +19.57% | ||
| 2024-05-16 | Sale | Brand Florian | See Remarks | 151,303 0.09% | $1.92 | $290,502 | -24.73% | |
| 2024-04-02 | Sale | Rao Srinivas | See Remarks | 61,640 0.0367% | $1.85 | $114,034 | -21.93% | |
| 2024-04-02 | Sale | Johnson Anne Nagengast | Chief Financial Officer | 27,410 0.0163% | $1.85 | $50,709 | -21.93% | |
| 2024-04-02 | Sale | Kirpekar Sahil | Chief Business Officer | 35,801 0.0213% | $1.85 | $66,232 | -21.93% | |
| 2023-11-16 | Brand Florian | See Remarks | 20,000 0.0125% | $1.16 | $23,120 | +33.33% | ||
| 2023-09-13 | Brand Florian | See Remarks | 40,000 0.0242% | $1.45 | $57,968 | +3.19% | ||
| 2023-03-29 | Apeiron Investment Group Ltd. | 10 percent owner | 1.21M 0.6461% | $1.32 | $1.6M | +8.80% | ||
| 2023-03-29 | Brand Florian | See Remarks | 70,000 0.0418% | $1.48 | $103,558 | +8.80% | ||
| 2022-04-28 | Angermayer Christian | 21,900 0.0144% | $4.47 | $97,801 | -28.96% | |||
| 2022-04-26 | Angermayer Christian | 19,803 0.013% | $4.64 | $91,939 | -31.30% | |||
| 2022-04-22 | Angermayer Christian | 52,820 0.0346% | $4.83 | $254,962 | -33.79% | |||
| 2022-04-20 | Angermayer Christian | 68,688 0.0434% | $4.95 | $340,040 | -37.52% |
| Apeiron Investment Group Ltd. | 10 percent owner | 51045214 27.0617% | $220.52M | 5 | 0 | <0.0001% |
| Rao Srinivas | See Remarks | 212942 0.1129% | $919,909.44 | 1 | 2 | <0.0001% |
| Johnson Anne Nagengast | Chief Financial Officer | 140045 0.0742% | $604,994.40 | 0 | 2 | |
| Kirpekar Sahil | Chief Business Officer | 115636 0.0613% | $499,547.52 | 0 | 2 | |
| Short Glenn Frank | Chief Scientific Officer | 42333 0.0224% | $182,878.56 | 0 | 1 | |
| Craig Kevin James | Chief Medical Officer | 8437 0.0045% | $36,447.84 | 0 | 1 | |
| Auerbach Michael | director | 5564474 2.95% | $24.04M | 1 | 0 | <0.0001% |
| Angermayer Christian | 1799302 0.9539% | $7.77M | 9 | 0 | <0.0001% | |
| Brand Florian | See Remarks | 328697 0.1743% | $1.42M | 4 | 1 | <0.0001% |
| WEAVER GREGORY L | Chief Financial Officer | 4666 0.0025% | $20,157.12 | 1 | 0 | <0.0001% |
| Kalali Amir H | director | 4666 0.0025% | $20,157.12 | 1 | 0 | <0.0001% |
| Smiley Andrea Heslin | director | 4666 0.0025% | $20,157.12 | 1 | 0 | <0.0001% |
| de Rosnay Alexis | director | 4666 0.0025% | $20,157.12 | 1 | 0 | <0.0001% |
| Increased Positions | 81 | +88.04% | 18M | +61.06% |
| Decreased Positions | 29 | -31.52% | 3M | -11.61% |
| New Positions | 48 | New | 12M | New |
| Sold Out Positions | 15 | Sold Out | 1M | Sold Out |
| Total Postitions | 144 | +56.52% | 44M | +49.45% |
| Ubs Group Ag | $29,865.00 | 2.12% | 7.68M | -22,470 | -0.29% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $21,141.00 | 1.5% | 5.43M | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $18,733.00 | 1.33% | 4.82M | +1M | +37.81% | 2025-09-30 |
| Citadel Advisors Llc | $10,021.00 | 0.71% | 2.58M | +1M | +118.39% | 2025-09-30 |
| Ally Bridge Group (Ny) Llc | $8,896.00 | 0.63% | 2.29M | +2M | New | 2025-09-30 |
| Ark Investment Management Llc | $7,856.00 | 0.56% | 2.02M | +2M | New | 2025-09-30 |
| T. Rowe Price Investment Management, Inc. | $7,546.00 | 0.53% | 1.94M | +2M | New | 2025-09-30 |
| Millennium Management Llc | $4,270.00 | 0.3% | 1.1M | -90,397 | -7.61% | 2025-09-30 |
| Pale Fire Capital Se | $4,204.00 | 0.3% | 1.08M | -2M | -59.07% | 2025-09-30 |
| Marshall Wace, Llp | $4,146.00 | 0.29% | 1.07M | +786,007 | +280.84% | 2025-09-30 |